Suppr超能文献

V-erbA发挥显性负性活性需要辅助蛋白。

V-erbA requires auxiliary proteins for dominant negative activity.

作者信息

Hermann T, Hoffmann B, Piedrafita F J, Zhang X K, Pfahl M

机构信息

Cancer Research Centre, La Jolla Cancer Research Foundation, California 92037.

出版信息

Oncogene. 1993 Jan;8(1):55-65.

PMID:8093812
Abstract

The avian v-erbA protein is an important example of a dominant negative oncogene. It has been identified as a highly mutated form of its cellular homolog, the thyroid hormone receptor alpha (TR-alpha), and its biological activity has been correlated with its repressor function on certain receptor-regulated genes. Although v-erbA has lost the hormone responsiveness of its cellular homolog, it has retained DNA-binding activity, and it has been implied that this function is required for repression and transformation. Here we demonstrate that v-erbA forms heterodimers with the retinoid X receptor (RXR-alpha). Only heteromeric v-erbA-RXR-alpha complexes show DNA-binding strong enough to account for its potent repressor function. In addition, v-erbA-RXR-alpha heterodimers specifically bind natural thyroid hormone-responsive elements (TREs) but not retinoic acid-responsive elements (RAREs). Repression of TRE-controlled gene expression by v-erbA requires the presence of RXR-alpha with the natural TREs tested. In contrast, natural RAREs investigated here do not bind the v-erbA-RXR-alpha heterodimer and also are not significantly repressed by v-erbA. Carboxy-terminal mutations that abolish v-erbA-RXR-alpha heterodimer formation also abolish v-erbA repressor activity. These data suggest that interaction of v-erbA with RXRs or similar auxiliary receptors is essential for the dominant negative activity of the v-erbA oncogene.

摘要

禽源v-erbA蛋白是显性负癌基因的一个重要例子。它已被鉴定为其细胞同源物甲状腺激素受体α(TR-α)的高度突变形式,其生物学活性与其对某些受体调节基因的抑制功能相关。尽管v-erbA已丧失其细胞同源物的激素反应性,但它保留了DNA结合活性,并且有人认为这种功能是抑制和转化所必需的。在这里,我们证明v-erbA与视黄酸X受体(RXR-α)形成异二聚体。只有异源的v-erbA-RXR-α复合物显示出足够强的DNA结合能力,足以解释其强大的抑制功能。此外,v-erbA-RXR-α异二聚体特异性结合天然甲状腺激素反应元件(TREs),但不结合视黄酸反应元件(RAREs)。v-erbA对TRE控制的基因表达的抑制需要RXR-α与所测试的天然TREs同时存在。相比之下,这里研究的天然RAREs不结合v-erbA-RXR-α异二聚体,也不会被v-erbA显著抑制。消除v-erbA-RXR-α异二聚体形成的羧基末端突变也会消除v-erbA的抑制活性。这些数据表明,v-erbA与RXRs或类似辅助受体的相互作用对于v-erbA癌基因的显性负活性至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验